159 related articles for article (PubMed ID: 27659181)
21. Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancer.
Chen K; Qian W; Jiang Z; Cheng L; Li J; Sun L; Zhou C; Gao L; Lei M; Yan B; Cao J; Duan W; Ma Q
Mol Cancer; 2017 Jul; 16(1):131. PubMed ID: 28738823
[TBL] [Abstract][Full Text] [Related]
22. Oxidative stress induced by inactivation of TP53INP1 cooperates with KrasG12D to initiate and promote pancreatic carcinogenesis in the murine pancreas.
Al Saati T; Clerc P; Hanoun N; Peuget S; Lulka H; Gigoux V; Capilla F; Béluchon B; Couvelard A; Selves J; Buscail L; Carrier A; Dusetti N; Dufresne M
Am J Pathol; 2013 Jun; 182(6):1996-2004. PubMed ID: 23578383
[TBL] [Abstract][Full Text] [Related]
23. Robust Early Inflammation of the Peripancreatic Visceral Adipose Tissue During Diet-Induced Obesity in the KrasG12D Model of Pancreatic Cancer.
Hertzer KM; Xu M; Moro A; Dawson DW; Du L; Li G; Chang HH; Stark AP; Jung X; Hines OJ; Eibl G
Pancreas; 2016 Mar; 45(3):458-65. PubMed ID: 26495779
[TBL] [Abstract][Full Text] [Related]
24. The synthetic triterpenoid (CDDO-Im) inhibits STAT3, as well as IL-17, and improves DSS-induced colitis in mice.
Fitzpatrick LR; Stonesifer E; Small JS; Liby KT
Inflammopharmacology; 2014 Dec; 22(6):341-9. PubMed ID: 24715223
[TBL] [Abstract][Full Text] [Related]
25. Novel synthetic pyridyl analogues of CDDO-Imidazolide are useful new tools in cancer prevention.
Cao M; Onyango EO; Williams CR; Royce DB; Gribble GW; Sporn MB; Liby KT
Pharmacol Res; 2015 Oct; 100():135-47. PubMed ID: 26238177
[TBL] [Abstract][Full Text] [Related]
26. GNAS(R201H) and Kras(G12D) cooperate to promote murine pancreatic tumorigenesis recapitulating human intraductal papillary mucinous neoplasm.
Taki K; Ohmuraya M; Tanji E; Komatsu H; Hashimoto D; Semba K; Araki K; Kawaguchi Y; Baba H; Furukawa T
Oncogene; 2016 May; 35(18):2407-12. PubMed ID: 26257060
[TBL] [Abstract][Full Text] [Related]
27. Differential effects of the Nrf2 activators tBHQ and CDDO-Im on the early events of T cell activation.
Zagorski JW; Turley AE; Freeborn RA; VanDenBerg KR; Dover HE; Kardell BR; Liby KT; Rockwell CE
Biochem Pharmacol; 2018 Jan; 147():67-76. PubMed ID: 29155145
[TBL] [Abstract][Full Text] [Related]
28. Activation Of Wild-Type Hras Suppresses The Earliest Stages Of Pancreatic Cancer.
Weyandt J
Redox Biol; 2015 Aug; 5():414. PubMed ID: 28162272
[TBL] [Abstract][Full Text] [Related]
29. Prolonged survival and delayed progression of pancreatic intraepithelial neoplasia in LSL-KrasG12D/+;Pdx-1-Cre mice by vitamin E δ-tocotrienol.
Husain K; Centeno BA; Chen DT; Fulp WJ; Perez M; Zhang Lee G; Luetteke N; Hingorani SR; Sebti SM; Malafa MP
Carcinogenesis; 2013 Apr; 34(4):858-63. PubMed ID: 23302291
[TBL] [Abstract][Full Text] [Related]
30. The novel synthetic triterpenoid, CDDO-imidazolide, inhibits inflammatory response and tumor growth in vivo.
Place AE; Suh N; Williams CR; Risingsong R; Honda T; Honda Y; Gribble GW; Leesnitzer LM; Stimmel JB; Willson TM; Rosen E; Sporn MB
Clin Cancer Res; 2003 Jul; 9(7):2798-806. PubMed ID: 12855660
[TBL] [Abstract][Full Text] [Related]
31. The conditional expression of KRAS G12D in mouse pancreas induces disorganization of endocrine islets prior the onset of ductal pre-cancerous lesions.
Gout J; Pommier RM; Vincent DF; Ripoche D; Goddard-Léon S; Colombe A; Treilleux I; Valcourt U; Tomasini R; Dufresne M; Bertolino P; Bartholin L
Pancreatology; 2013; 13(3):191-5. PubMed ID: 23719586
[TBL] [Abstract][Full Text] [Related]
32. Generation of a pancreatic cancer model using a Pdx1-Flp recombinase knock-in allele.
Wu J; Liu X; Nayak SG; Pitarresi JR; Cuitiño MC; Yu L; Hildreth BE; Thies KA; Schilling DJ; Fernandez SA; Leone G; Ostrowski MC
PLoS One; 2017; 12(9):e0184984. PubMed ID: 28934293
[TBL] [Abstract][Full Text] [Related]
33. The synthetic triterpenoid CDDO-Imidazolide suppresses STAT phosphorylation and induces apoptosis in myeloma and lung cancer cells.
Liby K; Voong N; Williams CR; Risingsong R; Royce DB; Honda T; Gribble GW; Sporn MB; Letterio JJ
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4288-93. PubMed ID: 16857804
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-1β-induced pancreatitis promotes pancreatic ductal adenocarcinoma via B lymphocyte-mediated immune suppression.
Takahashi R; Macchini M; Sunagawa M; Jiang Z; Tanaka T; Valenti G; Renz BW; White RA; Hayakawa Y; Westphalen CB; Tailor Y; Iuga AC; Gonda TA; Genkinger J; Olive KP; Wang TC
Gut; 2021 Feb; 70(2):330-341. PubMed ID: 32393543
[TBL] [Abstract][Full Text] [Related]
35. Sex-dependent development of Kras-induced anal squamous cell carcinoma in mice.
Walcheck MT; Matkowskyj KA; Turco A; Blaine-Sauer S; Nukaya M; Noel J; Ronnekleiv OK; Ronnekleiv-Kelly SM
PLoS One; 2021; 16(11):e0259245. PubMed ID: 34735515
[TBL] [Abstract][Full Text] [Related]
36. Synthetic triterpenoids prolong survival in a transgenic mouse model of pancreatic cancer.
Liby KT; Royce DB; Risingsong R; Williams CR; Maitra A; Hruban RH; Sporn MB
Cancer Prev Res (Phila); 2010 Nov; 3(11):1427-34. PubMed ID: 20959520
[TBL] [Abstract][Full Text] [Related]
37. Triterpenoids display single agent anti-tumor activity in a transgenic mouse model of chronic lymphocytic leukemia and small B cell lymphoma.
Kress CL; Konopleva M; Martínez-García V; Krajewska M; Lefebvre S; Hyer ML; McQueen T; Andreeff M; Reed JC; Zapata JM
PLoS One; 2007 Jun; 2(6):e559. PubMed ID: 17593960
[TBL] [Abstract][Full Text] [Related]
38. Vaccination with ENO1 DNA prolongs survival of genetically engineered mice with pancreatic cancer.
Cappello P; Rolla S; Chiarle R; Principe M; Cavallo F; Perconti G; Feo S; Giovarelli M; Novelli F
Gastroenterology; 2013 May; 144(5):1098-106. PubMed ID: 23333712
[TBL] [Abstract][Full Text] [Related]
39. Nr5a2 heterozygosity sensitises to, and cooperates with, inflammation in KRas(G12V)-driven pancreatic tumourigenesis.
Flandez M; Cendrowski J; Cañamero M; Salas A; del Pozo N; Schoonjans K; Real FX
Gut; 2014 Apr; 63(4):647-55. PubMed ID: 23598351
[TBL] [Abstract][Full Text] [Related]
40. The Synthetic Triterpenoid RTA 405 (CDDO-EA) Halts Progression of Liver Fibrosis and Reduces Hepatocellular Carcinoma Size Resulting in Increased Survival in an Experimental Model of Chronic Liver Injury.
Getachew Y; Cusimano FA; Gopal P; Reisman SA; Shay JW
Toxicol Sci; 2016 Jan; 149(1):111-20. PubMed ID: 26443840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
